Mouse Anti-Influenza A Virus H13 Subtype Haemagglutinin (HA) Monoclonal Antibody

The influenza A virus H13 subtype hemagglutinin (HA) is a surface glycoprotein that plays a pivotal role in the initial stages of viral infection. The HA protein mediates the attachment of the virus to host cell receptors and facilitates membrane fusion, allowing the release of the viral genome into the host cell. This protein is a major target for the host immune response and is subject to antigenic drift, which can lead to the emergence of new virus strains. The HA of the influenza A virus H13 subtype is a prime target for antiviral development due to its critical function in viral entry. Neutralizing antibodies against the HA protein can prevent the virus from binding to host cells, thereby inhibiting infection. Additionally, the HA protein is a key component of influenza vaccines, as it elicits an immune response that provides protection against infection.